June 20, 2002  —  Personal Finance
Biotech Bargains?
Sectoral Asset Management's Michael Sjostrom thinks some stocks in this beaten-down group look attractive now, including Gilead Sciences and InterMune

These clips require RealPlayer
 Download RealPlayer here



Copyright 2001-2002, Bloomberg L.P.
Terms of Use | Privacy Policy | Video comments: video@businessweek.com